Gage Growth Corp.  a leading high-quality premium cannabis brand and operator in Michigan is pleased to announce that, at the special meeting of its shareholders held yesterday a significant majority of Shareholders voted in favor of the special resolution approving the previously announced plan of arrangement under Section 192 of the Canada Business Corporations Act pursuant to which TerrAscend Corp. will acquire ...

Gage Growth Corp. (" Gage " or the " Company ") (CSE: GAGE) (OTCQX: GAEGF), a leading high-quality premium cannabis brand and operator in Michigan is pleased to announce that, at the special meeting of its shareholders (the " Shareholders ") held yesterday (the " Meeting "), a significant majority of Shareholders voted in favor of the special resolution (the " Arrangement Resolution ") approving the previously announced plan of arrangement under Section 192 of the Canada Business Corporations Act pursuant to which TerrAscend Corp. will acquire all of the issued and outstanding subordinate voting shares of Gage (the " Arrangement ").

Shareholders carrying an aggregate of 120,076,552 votes, representing approximately 56.26% of votes entitled to be cast at the Meeting, were represented in person or by proxy at the Meeting. The Arrangement Resolution was approved by 99.57% of the votes cast by Shareholders, voting together as a single class, as well as 99.22% of the votes cast by the Shareholders, excluding the votes attached to the shares directly or indirectly held or controlled by Mike Hermiz , Jason Wild and Richard Mavrinac , whose votes are required to be excluded in determining minority approval pursuant to National Instrument 61-101 – Protection of Minority Security Holders in Special Transactions .

"We are pleased that Gage shareholders have expressed their support not only for this transaction but also for the Company's vision to strategically expand its brand footprint in a variety of new markets," said Fabian Monaco , CEO of Gage. "Our team looks forward to joining forces with TerrAscend to create higher industry standards in cultivation, processing, branding and consumer experiences, as mainstream demand accelerates throughout the country."

The Arrangement remains subject to customary closing conditions, including the approval of the Ontario Superior Court of Justice (Commercial List) in the City of Toronto and the receipt of certain cannabis regulatory approvals in the State of Michigan . Following completion of the Arrangement, Gage shares will be de-listed from the Canadian Securities Exchange (the " CSE ") and applications will be made for it to cease to be a reporting issuer with the relevant securities regulatory authorities.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About Gage Growth Corp.

Gage Growth Corp. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm's founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage's portfolio includes city and state approvals for 19 "Class C" cultivation licenses, three processing licenses and 15 provisioning centers (dispensaries).

For more information about Gage Growth Corp., visit www.gagecannabis.com or www.gageinvestors.com .

Instagram: @gagemichigan
Facebook: @gageusa
Twitter: @gagecannabisco

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States . While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation.

Explanatory Note Regarding the Company ' s Operations

References in this news release to the Company and its operations and portfolio are inclusive of the operations and assets of certain licensed cannabis operators that operate under the Gage brand pursuant to contractual arrangements with the Company. For additional information, please refer to the Company ' s long form prospectus dated March 26, 2021 and other disclosure documents available on the Company ' s profile at www.sedar.com .

Forward Looking Information

This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions, and include, but are not limited to statements with respect to the anticipated completion of the Arrangement and the satisfaction of closing conditions of the Arrangement which include, without limitation: (i) required court approval, (ii) obtaining the necessary approvals from the CSE for the listing of the TerrAscend Corp. securities issuable in connection with the Arrangement; (iii) the required state and municipal regulatory approvals; and (iv) other approvals and closing conditions contained in the arrangement agreement between TerrAscend Corp. and Gage dated August 31, 2021 , as amended. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information including, but not limited to, those risks disclosed in the Company ' s most recently filed management's discussion and analysis and other disclosure documents available on the Company ' s profile at www.sedar.com . The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/gage-shareholders-overwhelmingly-approve-the-terrascend-arrangement-301422855.html

SOURCE Gage Cannabis Co.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2021/12/c0064.html

News Provided by Canada Newswire via QuoteMedia

HEMPSANA Announces Q3 2021 Financial Results

HEMPSANA Announces Q3 2021 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

Hempsana Holdings Ltd. (the " Company " or " Hempsana ") today announced third quarter ("Q3") financial results for the three- and nine-month period ended September 30, 2021.

Keep reading... Show less
cannabis plant layered with German flag graphic

Cannabis Weekly Round-Up: Germany Moves Ahead on Path to Adult Use

Three political parties have formed a coalition in Germany, leading to a new government, and it has promised cannabis reform in the European nation.

Meanwhile, a popular cannabis retailer confirmed consumers will now find its products available for delivery on the Uber Eats mobile application in Ontario.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading... Show less
Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

 Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has received conditional approval from the Toronto Stock Exchange ("TSX") to graduate its listing from the TSX Venture Exchange (the "TSXV") to the TSX.

"This is an important milestone for Numinus, as we take key steps to heighten our corporate profile and reach a broader range of investors," said Payton Nyquvest , Founder and CEO of Numinus. "Today's announcement is reflective of many exciting developments occurring at Numinus. We're actively growing our clinic network across North America , expanding our lab capabilities, and strategically investing in clinical research to drive long-term value creation for our investors."

Keep reading... Show less
MediPharm Labs Completes Medical Cannabis Export to Barbados

MediPharm Labs Completes Medical Cannabis Export to Barbados

  • Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.
  • This marks the fourth new country entered by MediPharm Labs in 2021, following initial shipments to Germany, Brazil and Peru.

MediPharm Labs Corp . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a medical cannabis export to Barbados in conjunction with strategic partner Avicanna (TSX: AVCN).

"Our GMP platform make us the go-to partner for companies looking to access global medical cannabis programs," said Bryan Howcroft, CEO, MediPharm Labs. "As countries around the world continue to adopt medical cannabis programs, MediPharm Labs is best positioned to serve these markets as the only North American producer with a Drug Establishment License (GMP) for the extraction of natural cannabinoids."

Keep reading... Show less
Numinus Announces Departure of Stacey Wallin

Numinus Announces Departure of Stacey Wallin

Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, announced today following the conclusion of several weeks of discussions that Stacey Wallin former Chief Strategy Officer, is no longer with the Company.

Keep reading... Show less
cannabis plants over growing piles of coins

VIDEO — Expert: Cannabis Investments Need US Reform in 2022

Expert: Cannabis Investments Need US Reform in 2022 youtu.be

As the year wraps up, one of the top cannabis investment experts breaks down his 2021 highlights and the expectations investors should have for 2022.

The Investing News Network (INN) sat down with Dan Ahrens, chief operating officer and portfolio manager with AdvisorShares, to get his perspective on what investors will remember about 2021 and what's next in the space.

Ahrens, an author and manager of two noteworthy cannabis public funds — the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) — is encouraged by what's ahead.

Keep reading... Show less

Top News

Related News